| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30087129 | HIV | ENSG00000168398.7 | protein_coding | BDKRB2 | No | No | 624 | P30411 |
| TVIS30037161 | HIV | ENSG00000168398.7 | protein_coding | BDKRB2 | No | No | 624 | P30411 |
| TVIS20051942 | HPV | ENSG00000168398.7 | protein_coding | BDKRB2 | No | No | 624 | P30411 |
| TVIS44006925 | HTLV-1 | ENSG00000168398.7 | protein_coding | BDKRB2 | No | No | 624 | P30411 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BDKRB2 |
|---|---|
| DrugBank ID | DB05038 |
| Drug Name | Anatibant |
| Target ID | BE0003513 |
| UniProt ID | P30411 |
| Regulation Type | antagonist |
| PubMed IDs | 10596852 |
| Citations | Pruneau D, Paquet JL, Luccarini JM, Defrene E, Fouchet C, Franck RM, Loillier B, Robert C, Belichard P, Duclos H, Cremers B, Dodey P: Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology. 1999 Sep;43(2-3):187-94. |
| Groups | Investigational |
| Direct Classification | Proline and derivatives |
| SMILES | CC1=CC(C)=C2C=CC=C(OCC3=C(Cl)C=CC(=C3Cl)S(=O)(=O)N3CCC[C@H]3C(=O)NCCCNC(=O)C3=CC=C(C=C3)C(N)=N)C2=N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2107725 |
